维普中文期刊产品整合服务
35篇 您的检索式:作者名="Koke I"
    题名 作者 年代 出处 被引量
1Platelet glycoprotein Ilb/IIIareceptor blockade improves vascular nitric oxide bioavailability inpatients with coronary artery disease 显示文摘Heitzer T Oilmann I Koke K 2003Circulation2003,108,5:1
2Product market competition, corporate governance and firm performance: an empirical analysis for germany 显示文摘JANUSZEWSKI S I KOKE F J WINTER J K 2002Research in Economics2002,56,2:1
3Platelet Glycoprotein Ⅱb/Ⅲa Receptor Blockade Improves Vascular Nitric Oxide Bioavailability in Patients With Coronary ArteryDisease显示文摘Heitzer T Oflmann I Koke 2003Circulation2003,108,:1
4Platelet glycoprotein II b/III a receptor blockade improves vascular nitric oxide bioavailability in patients with coronary artery disease显示文摘Heitzer T Oilmann I Koke K 2003Circulation2003,108,5:1
5Platelet glycoprotein IIb/IIIa receptor blockade improves vascular nitric oxide bioavail-ability in patients with coronary artery disease 显示文摘HEITZER T OLLMANN I KOKE K 2003Circulation2003,108,5:1
6Platelet glycoprotein Ⅱb/Ⅲa receptor blockade improves vascular nitric oxide bioavailability in patients with coronary artery disease显示文摘Heitzer T Ollmann I Koke K 2003Circulation2003,108,5:1
7Platelet glycoprotein II b/Ill a receptor blockade improves vascular nitric oxide bio- availability in patients with coronary artery disease 显示文摘Heitzer T Ollmann I Koke 2003Circulation2003,108,5:1
8Product Market Compe- tition, Corporate Governance and Firm Performance: An Empiri- cal Analysis for Germany显示文摘Januszewski S I J KOKE J WINTER J 2002Research in Economics2002,56,3:1
9Platelet Glycoprotein Ⅱb/Ⅲa Receptor Blockade Improves Vascular Nitric Oxide Bioavailability in Patients With Coronary Artery Disease 显示文摘Heitzer T Ollmann I Koke K 2003Circulation2003,108,5:1
10Platelet glycoprotein IIb/IIIa receptor blockade improves vascular nitric oxide bioavailability in patients with coronary artery disease显示文摘HEITZER T OLLMANN I KOKE K 2003Circulation2003,108,:1
11platelet glycoprotein Ⅱb/Ⅲa receptor blockade improves vascular nitric oxide bioavailability in patients with coronary artery disease显示文摘Heitzer T Ollmann I Koke K 2003Circulation2003,108,5:1
12Product Market Competition, Corporate Governance and Finn Performance: An empirical Analysis for Germany显示文摘Januszewski I Koke F Joachim K 1999JEL1999,,12:1
13Platelet glycoprotein Ilb/lIIa receptor blockade improves vascular nitric oxide bioavailability in patients with coronary artery disease 显示文摘Heitzer T Ollmann I Koke K 2003Circulation2003,108,5:1
14Product Market Competition, Corporate Governance and Firm Performance:An Empir- ical Analysis for Germany 显示文摘JANUSZEWSKI S I KOKE J WINTER J K 2002Research in Economics2002,56,:1
15Platelet glycoprotein Ⅱb/Ⅲa receptor blockade improves vascular nitric oxide bioavailability in patients with coronary artery disease显示文摘Heitzer T Ollmann I Koke K 2003Circulation2003,108,5:1
16Platelet glycoprotein Ⅱb/Ⅲ a receptor blockade improves vascular nitric oxide bioavailability in patients with coronary artery disease 显示文摘Heitzer T Oilmann I Koke K 2003Circulation2003,08,5:1
17Platelet glycoprotein Ⅱ b/Ⅲ a receptor blockade improves vascular nitric oxide bioavailability in patients with coronary artery disease显示文摘Heitzer T Ollmann I Koke K 2003Circulation2003,108,5:1
18Platelet glycoprotein Ⅱb/Ⅲa receptor blockade improves vascular nitric oxide bioavailability in patients with coronary artery disease 显示文摘Heitzer T Ollmann I Koke K 2003Circulation2003,108,5:1
19Product Market Competition, Corporate Governance and Firm Performance:An Empirical Analysis for Germany 显示文摘Januszewski I S Koke J Winter J 2002Research in Economics2002,56,3:1
20Platelet glycoprotein II b/Ⅲareceptor blockade improves vascular nitric oxide bioavailability in pa-tients with coronary artery disease显示文摘Heitzer T Ollmann I Koke K 2003Circulation2003,108,5:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费